Nanexa AB (publ) (STO:NANEXA)
2.340
+0.020 (0.86%)
Sep 3, 2025, 4:48 PM CET
Nanexa AB Revenue
Nanexa AB had revenue of 8.83M SEK in the quarter ending June 30, 2025, a decrease of -17.73%. This brings the company's revenue in the last twelve months to 38.40M, down -28.08% year-over-year. In the year 2024, Nanexa AB had annual revenue of 46.69M, down -21.07%.
Revenue (ttm)
38.40M
Revenue Growth
-28.08%
P/S Ratio
9.48
Revenue / Employee
2.56M
Employees
13
Market Cap
364.03M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 46.69M | -12.47M | -21.07% |
Dec 31, 2023 | 59.16M | 31.99M | 117.72% |
Dec 31, 2022 | 27.17M | 9.16M | 50.87% |
Dec 31, 2021 | 18.01M | -2.85M | -13.66% |
Dec 31, 2020 | 20.86M | 12.13M | 138.93% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.97B |
Sectra AB | 3.31B |
Getinge AB | 35.50B |
Camurus AB | 2.27B |
Medicover AB | 25.22B |
Asker Healthcare Group AB | 15.88B |
BioArctic AB | 1.86B |
AddLife AB | 10.44B |